Disease details

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00873340 (ClinicalTrials.gov)	October 2007	31/3/2009	Physical Disability in Patients Treated With Betaferon	Physical Disability Observational Study in Patients Treated With Betaferon in Daily Practice	Multiple Sclerosis	Drug: Interferon-1beta (Betaseron, BAY86-5046)	Bayer	NULL	Completed	18 Years	N/A	Both	83	N/A	Colombia
2	NCT00461396 (ClinicalTrials.gov)	May 2007	17/4/2007	Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron	Open-Label, Multicenter, Observational, Phase IV Study to Evaluate the Adherence to Treatment With 250mcg (8MIU) IFNB-1b (Betaseron®) Given Subcutaneous Every Other Day Over a Period of up to 12 Months in Patients With a First Clinical Demyelinating Event Suggestive of Multiple Sclerosis and Patients With Onset of Relapsing-Remitting Multiple Sclerosis (RRMS) Within the Past 12 Months	Multiple Sclerosis;Multiple Sclerosis, Relapsing-Remitting	Drug: Interferon-1beta (Betaseron, BAY86-5046)	Bayer	NULL	Completed	18 Years	50 Years	Both	104	Phase 4	United States